Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA

@inproceedings{McCool2017SystematicRA,
  title={Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA},
  author={Rachael McCool and Ian Malcolm Gould and Jacqui Eales and Teresa Barata and Mick Arber and Kelly Fleetwood and Julie M. Glanville and Teresa L. Kauf},
  booktitle={BMC infectious diseases},
  year={2017}
}
BACKGROUND Tedizolid, the active moiety of tedizolid phosphate, is approved in the United States, the European Union, Canada and a number of other countries for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This network meta-analysis (NMA) evaluates the comparative effectiveness of tedizolid and other antibacterials indicated for the treatment of ABSSSI caused by… CONTINUE READING